| ESS<10 | ESS>10 | |||
| FIS<29 | FIS>29 | FIS<29 | FIS>29 | |
| n | 47 | 34 | 12 | 27 |
| Females (%) | 20 (43%) | 16 (47%) | 3 (25%) | 13 (52%) |
| Age (years) mean (SD) | 55 (13) | 52(14) | 46 (14) | 54 (9) |
| BMI (kg/m2) | 34 (5) | 35 (6) | 33 (5) | 37 (5) |
| HOMA | 9 (8) | 5 (4) | 5 (5) | 8 (6) |
| ALB (g/l) | 44 (4) | 43 (4) | 45 (3) | 43 (4) |
| Bil (µmol/l) | 15 (15) | 11 (7) | 15 (10) | 15 (15) |
| ALP (U/l) | 111 (72) | 124 (53) | 101 (59) | 99 (40) |
| ALT (U/l) | 83 (58) | 101 (87) | 123 (83) | 85 (45) |
| Fibrosis (1–6) | 2.6 (2.3) | 3.9 (2.0) | 2.0 (1.8) | 3.0 (2.4) |
| Steatosis (0–3) | 2.1 (0.6) | 2.1 (0.8) | 1.8 (0.7) | 2.2 (0.7) |
None of the comparisons is significant (by analysis of variance).
ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Bil, bilirubin; BMI, body mass index; ESS, Epworth Sleepiness Score; FIS, Fatigue Impact Scale; HOMA, homeostasis model assessment; NAFLD, non-alcoholic fatty liver disease.